The federal government releases Medicare Advantage quality star ratings for 2027, and Humana is widely cited as a major beneficiary. STAT News reports that the updated ratings affect how insurers earn new quality-based bonuses, while still leaving uncertainty around how Medicare Advantage quality measures will ultimately work.
Quartz and Healthcare Dive both describe a more mixed industry picture alongside Humana’s gains. Quartz notes Humana says 95% of its Medicare Advantage members will be in plans rated 4 stars or higher in 2027, compared with 20% in 2026, and links that improvement to a sharp rise in the company’s stock. Healthcare Dive’s analysis similarly finds a mix of winners and losers across large carriers, while also reporting that quality scores generally decline overall for 2027.
Across outlets, the central context is that the stars determine financial incentives and reflect insurer performance on quality metrics, but the measurement and policy environment creates uncertainty about how future ratings and incentives will evolve.
